Neuropsychological and CSF markers of early and late Alzheimer's disease

被引:0
|
作者
Contardo, C.
Walker, A.
Wagner, M.
机构
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:675 / 675
页数:1
相关论文
共 50 条
  • [21] Early Diagnosis of Alzheimer's Disease with Cognitive Neuropsychological Tests
    Yang, Jiajia
    Shen, Yong
    Wu, Jinglong
    2009 ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, 2009, : 81 - +
  • [22] Cognitive screening and neuropsychological assessment in early Alzheimer's disease
    Salmon, DP
    Lange, KL
    CLINICS IN GERIATRIC MEDICINE, 2001, 17 (02) : 229 - +
  • [23] Working memory in early Alzheimer's disease: a neuropsychological review
    Huntley, J. D.
    Howard, R. J.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 25 (02) : 121 - 132
  • [24] Early diagnosis of Alzheimer's disease with simple neuropsychological tests
    Orgogozo, JM
    Fabrigoule, C
    Dartigues, JF
    ALZHEIMER'S DISEASE AND RELATED DISORDERS: ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 1999, : 127 - 135
  • [25] CSF tau markers are correlated with hippocampal volume in Alzheimer's disease
    de Souza, Leonardo C.
    Chupin, Marie
    Lamari, Foudil
    Jardel, Claude
    Leclercq, Delphine
    Colliot, Olivier
    Lehericy, Stephane
    Dubois, Bruno
    Sarazin, Marie
    NEUROBIOLOGY OF AGING, 2012, 33 (07) : 1253 - 1257
  • [26] CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease
    Schoonenboom, Niki S. M.
    van der Flier, Wiesje M.
    Blankenstein, Marinus A.
    Bouwman, Femke H.
    Van Kamp, Gerard J.
    Barkhof, Frederik
    Scheltens, Philip
    NEUROBIOLOGY OF AGING, 2008, 29 (05) : 669 - 675
  • [27] Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease
    Popp, Julius
    Meichsner, Sabrina
    Koelsch, Heike
    Lewczuk, Piotr
    Maier, Wolfgang
    Kornhuber, Johannes
    Jessen, Frank
    Luetjohann, Dieter
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (01) : 37 - 42
  • [28] RELATION OF CSF MARKERS TO DRUG EFFECTS IN ALZHEIMER'S DISEASE TRIALS
    Blennow, Kaj
    NEUROBIOLOGY OF AGING, 2016, 39 : S5 - S6
  • [29] Diagnosing prodromal Alzheimer's disease: Role of CSF biochemical markers
    Parnetti, L
    Lanari, A
    Silvestrelli, G
    Saggese, E
    Reboldi, P
    MECHANISMS OF AGEING AND DEVELOPMENT, 2006, 127 (02) : 129 - 132
  • [30] Elevation of CSF tau in early stage Alzheimer's disease
    Seubert, P
    Motter, R
    Schenk, D
    Green, R
    Chang, L
    Miller, B
    Clark, C
    Galasko, D
    NEUROLOGY, 1996, 46 (02) : 5001 - 5001